×

Colorado Caps Insulin Co-Pay Costs at $100 a Month

The new law doesn't addressed those who have to pay list price for insulin, however.

Articles

Theresa May, a UK Prime Minister with Type 1 Diabetes, Resigns

Prime Minister May is apparently the first world leader who has openly served with type 1 diabetes.

A Type 1 Diabetes Diagnosis Has Helped This Doctor Help Patients with Diabetes

A profile of Dr. Michael Heile of The Family Medical Group-Cincinnati.

Colorado Law Caps Insulin Monthly Insulin Costs at $100 for Insured Patients

-Craig Idlebrook Yesterday, Colorado governor Jared Polis signed into law a measure that will cap total monthly insurance co-pays for insulin at $100. All insurers in the state will have to comply with the new regulation by January 1st, 2020. The measure caps out-of-pocket costs for a 30-day supply of insulin at $100 for Coloradans […]

A father who was diagnosed with type 1 diabetes later in life describes how his family has rallied behind him after his diagnosis, and how the 24/7 blood sugar management is still difficult despite the help.

Senseonics announced a distribution partnership with a verified Service-Disabled Veteran-Owned Small Business to offer the implantable CGM through the Veterans Health Administration.

DIY Automated Insulin Dosing Stakeholders Issue Statement to FDA Warning Against Such Systems

The statement has reportedly been endorsed and co-written by key members of the Loop, OpenAPS, and AndroidAPS movements.

The agency says it has received word of an accidental insulin overdose that occurred with an automated insulin dosing system.

AOC Brings Insulin Prices Into Hearing on Price-Gouging by Military Contracts

The congresswoman totals up how many vials of insulin the government could buy for the price charged for a batch of small clutch disks.

FDA Delays Decision on Eli Lilly’s Nasal Glucagon

Eli Lilly and Company is currently seeking FDA approval for their nasal glucagon, but a recent decision delay may set back their timeline for bringing the treatment to market.

Kentucky Attorney General Sues Insulin Makers of Alleged Pricing Scheme

In a lawsuit, he accuses Novo Nordisk, Lilly, and Sanofi of reporting inaccurately high list prices to drive up profits for both insulin makers and pharmacy benefit managers.